Finally, as displayed in Table 5, in MDA-MB-231 BC cell line the Cur-SLN treatment activate specific set of genes controlling cell cycle process, TGF-beta pathway, TNF signaling, phosphatidylinositol signaling and FoxO signaling pathway. This evidence concerns the gene TNF and breast cancer.